Stock listing

6Z4 Stock Price, News, Filings & Events — Crinetics Pharmaceuticals, Inc.

Selected listing: 6Z4 · GETTEX · EUR · DE

The 6Z4:GETTEX listing represents Crinetics Pharmaceuticals, Inc., a biopharmaceutical company focused on developing innovative therapies for endocrine diseases and disorders. The company is actively advancing its pipeline of drug candidates and has recently made headlines with updates on clinical trials and regulatory filings. Investors can stay informed about upcoming events and market developments that may impact the company's performance. Crinetics continues to navigate the evolving landscape of the biopharmaceutical sector, positioning itself for future growth.

6Z4:GETTEXEURDEUpdated July 24, 2026
Crinetics Pharmaceuticals, Inc. logo
Ticker
6Z4:GETTEX
Asset type
Stock
Market cap
$8.87B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
GETTEX
Currency
EUR

Crinetics Pharmaceuticals, Inc. 6Z4:GETTEX stock context

The 6Z4:GETTEX listing represents Crinetics Pharmaceuticals, Inc., a biopharmaceutical company focused on developing innovative therapies for endocrine diseases and disorders. The company is actively advancing its pipeline of drug candidates and has recently made headlines with updates on clinical trials and regulatory filings. Investors can stay informed about upcoming events and market developments that may impact the company's performance. Crinetics continues to navigate the evolving landscape of the biopharmaceutical sector, positioning itself for future growth.

Research Crinetics Pharmaceuticals, Inc.

Alternate listings